SPYRE THERAPEUTICS, INC. (SYRE) Revenue 2016–2025
SPYRE THERAPEUTICS, INC. (SYRE) annual revenue history from SEC filings — each fiscal year as reported, with year-over-year change.
$0FY2025 · since FY2016: $4.6M → $0
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | $0 | — |
| FY2024 | $0 | -100.0% |
| FY2023 | $886,000 | -62.0% |
| FY2022 | $2.3M | -87.6% |
| FY2021 | $18.7M | — |
| FY2020 | $0 | — |
| FY2019 | $0 | -100.0% |
| FY2018 | $3.9M | -25.3% |
| FY2017 | $5.2M | +12.5% |
| FY2016 | $4.6M | — |
Source: SEC XBRL filings · For reference only · Not investment advice
More SYRE financial trends
SYRE Net incomeSYRE Net marginSYRE Gross profitSYRE Gross marginSYRE Operating incomeSYRE Operating marginSYRE Operating cash flowSYRE Free cash flowSYRE Capital expendituresSYRE Return on equitySYRE Stock buybacksSYRE Dividends paidSYRE Total assetsSYRE Total liabilitiesSYRE Shareholders’ equitySYRE overview →